Omicron variant Latest Update
BioNTech, a German biotechnology company that makes vaccines, has begun the development of a new Covid-19 vaccine to combat the Omicron variant.
According to reports, the vaccine manufacturer, which collaborates with Pfizer on Covid-19 vaccines, has begun developing an adapted vaccine for Omicron to allow it to move forward quickly.
While investigating and researching the nature of the new Omicron variant of the Coronavirus, the vaccine will be used as a precautionary measure.
Scientists and health officials from all over the world are keeping a close eye on Omicron, also known as B.1.1.529, which was first discovered in southern Africa. The new variant, according to public health experts, shows signs of being more transmissible or dangerous than other strains of the disease.
On Monday, November 29, a BioNTech spokesperson stated that to avoid wasting time, the company was developing an updated vaccine as well as testing its existing shot pending the availability of data.
What BioNTech’s spokesperson has to say
“We understand the concerns of experts and have immediately begun investigations on the omicron variant (B.1.1.529) as well as the development of an adapted vaccine as part of our standard procedure for new variants,” BioNTech said in a statement.
“The preliminary stages of developing a potential new vaccine overlap with the research required to determine whether a new shot is required. The goal of this strategy, which began last Thursday, is to move forward quickly if a variant-specific vaccine is required.
“The results of the laboratory tests should be available in about two weeks.” These findings will help determine whether B.1.1.529 is an escape variant that may necessitate a vaccine adjustment if the variant spreads globally.”
Because it had additional mutations on the spike protein, BioNTech said the new variant was significantly different from previously observed variants.
It also stated that if a new variant emerged, it would be able to ship out new versions of the COVID-19 vaccine within 100 days.
- Covid symptoms linked to the new omicron variant have been described as “extremely mild” by the South African doctor who first raised the alarm over the new strain.
- Dr Angelique Coetzee told the BBC on Sunday that the patients seen so far have had “extremely mild symptoms.”
- The WHO has said it will take weeks to understand how the variant may affect diagnostics, therapeutics and vaccines.
The new Omicron strain of Covid has been discovered in two people who recently travelled to Nigeria, according to Canada.
On Sunday, the Ontario government confirmed that the two cases are in the capital, Ottawa.
Both patients are in isolation, according to federal and provincial officials in Ontario, while public health authorities investigate their possible contacts. According to Punch,
What you need to know about the Omicron variant
Recall that the World Health Organization (WHO) recently designated Omicron as a “variant of concern,” even though officials have stressed that little is known about the variant at this time.
The new Omicron Covid-19 variant, which was first discovered in South Africa, has now spread to countries such as the United Kingdom, Portugal, the Netherlands, Italy, Germany, Belgium, Canada, Australia, Israel, and Hong Kong, among others.
However, the true extent of the omicron variant’s global spread is unknown, as new cases are discovered every day in different countries.
Hot Jobs In Nigeria
- Nigerian Breweries Graduate Management Development Scheme 2022
- Asaba Specialist Hospital Massive Job Recruitment for Graduates and Non-Graduate
- Landmark University Recruitment for Non Academic staff
- FMDQ Holdings Plc Graduate Development Programme 2022
- Dufil Prima Foods Plc Graduate Trainee Recruitment 2021/2022
- BUA Group Graduate Trainee Recruitment 2022